nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—CYP2C19—prostate cancer	0.184	1	CbGaD
Telmisartan—SLCO1B3—Cabazitaxel—prostate cancer	0.0632	0.119	CbGbCtD
Telmisartan—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0404	0.076	CbGbCtD
Telmisartan—SLCO1B3—Estradiol—prostate cancer	0.0355	0.0667	CbGbCtD
Telmisartan—ABCG2—Cabazitaxel—prostate cancer	0.0292	0.055	CbGbCtD
Telmisartan—ABCG2—Estrone—prostate cancer	0.0286	0.0538	CbGbCtD
Telmisartan—ABCC2—Ethinyl Estradiol—prostate cancer	0.0282	0.053	CbGbCtD
Telmisartan—CYP2C19—Bicalutamide—prostate cancer	0.0213	0.0401	CbGbCtD
Telmisartan—CYP2C19—Nilutamide—prostate cancer	0.0213	0.0401	CbGbCtD
Telmisartan—SLCO1B3—Docetaxel—prostate cancer	0.0212	0.0399	CbGbCtD
Telmisartan—ABCC2—Conjugated Estrogens—prostate cancer	0.0207	0.0389	CbGbCtD
Telmisartan—ABCG2—Conjugated Estrogens—prostate cancer	0.0187	0.0352	CbGbCtD
Telmisartan—CYP2C19—Flutamide—prostate cancer	0.0177	0.0332	CbGbCtD
Telmisartan—ABCG2—Mitoxantrone—prostate cancer	0.017	0.032	CbGbCtD
Telmisartan—ABCG2—Estradiol—prostate cancer	0.0164	0.0309	CbGbCtD
Telmisartan—ABCB1—Estramustine—prostate cancer	0.016	0.0301	CbGbCtD
Telmisartan—ABCC2—Etoposide—prostate cancer	0.0119	0.0223	CbGbCtD
Telmisartan—ABCC2—Docetaxel—prostate cancer	0.0108	0.0204	CbGbCtD
Telmisartan—ABCG2—Etoposide—prostate cancer	0.0107	0.0202	CbGbCtD
Telmisartan—ABCB1—Cabazitaxel—prostate cancer	0.0105	0.0198	CbGbCtD
Telmisartan—ABCB1—Estrone—prostate cancer	0.0103	0.0194	CbGbCtD
Telmisartan—ABCG2—Docetaxel—prostate cancer	0.00981	0.0184	CbGbCtD
Telmisartan—ABCB1—Ethinyl Estradiol—prostate cancer	0.00919	0.0173	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—prostate cancer	0.00809	0.0152	CbGbCtD
Telmisartan—CYP2C19—Estradiol—prostate cancer	0.00734	0.0138	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—prostate cancer	0.00731	0.0138	CbGbCtD
Telmisartan—ABCB1—Conjugated Estrogens—prostate cancer	0.00674	0.0127	CbGbCtD
Telmisartan—CYP2C19—Prednisone—prostate cancer	0.00631	0.0119	CbGbCtD
Telmisartan—ABCB1—Mitoxantrone—prostate cancer	0.00613	0.0115	CbGbCtD
Telmisartan—ABCB1—Estradiol—prostate cancer	0.00592	0.0111	CbGbCtD
Telmisartan—ABCB1—Prednisone—prostate cancer	0.00509	0.00957	CbGbCtD
Telmisartan—ABCB1—Etoposide—prostate cancer	0.00387	0.00727	CbGbCtD
Telmisartan—ABCB1—Docetaxel—prostate cancer	0.00354	0.00665	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—prostate cancer	0.00264	0.00496	CbGbCtD
Telmisartan—CYP2C19—urine—prostate cancer	0.0025	0.127	CbGeAlD
Telmisartan—Losartan—UGT2B17—prostate cancer	0.00226	0.674	CrCbGaD
Telmisartan—AGTR1—prostate gland—prostate cancer	0.00144	0.0735	CbGeAlD
Telmisartan—PPARG—Teniposide—Etoposide—prostate cancer	0.00141	1	CbGdCrCtD
Telmisartan—PPARG—prostate gland—prostate cancer	0.00119	0.0604	CbGeAlD
Telmisartan—AGTR1—epithelium—prostate cancer	0.00106	0.054	CbGeAlD
Telmisartan—ABCC2—prostate gland—prostate cancer	0.00104	0.0531	CbGeAlD
Telmisartan—AGTR1—renal system—prostate cancer	0.000983	0.0501	CbGeAlD
Telmisartan—PPARG—epithelium—prostate cancer	0.000872	0.0444	CbGeAlD
Telmisartan—PPARG—renal system—prostate cancer	0.000808	0.0412	CbGeAlD
Telmisartan—PPARG—urethra—prostate cancer	0.000794	0.0405	CbGeAlD
Telmisartan—ABCG2—prostate gland—prostate cancer	0.00076	0.0387	CbGeAlD
Telmisartan—ABCC2—renal system—prostate cancer	0.000711	0.0362	CbGeAlD
Telmisartan—ABCG2—seminal vesicle—prostate cancer	0.000643	0.0328	CbGeAlD
Telmisartan—AGTR1—testis—prostate cancer	0.000635	0.0324	CbGeAlD
Telmisartan—PPARG—bone marrow—prostate cancer	0.000611	0.0311	CbGeAlD
Telmisartan—PPARG—testis—prostate cancer	0.000523	0.0266	CbGeAlD
Telmisartan—ABCG2—urethra—prostate cancer	0.000509	0.0259	CbGeAlD
Telmisartan—AGTR1—lymph node—prostate cancer	0.000461	0.0235	CbGeAlD
Telmisartan—ABCC2—testis—prostate cancer	0.000459	0.0234	CbGeAlD
Telmisartan—Deferasirox—CYP3A4—prostate cancer	0.00041	0.122	CrCbGaD
Telmisartan—ABCG2—bone marrow—prostate cancer	0.000392	0.02	CbGeAlD
Telmisartan—PPARG—lymph node—prostate cancer	0.000379	0.0193	CbGeAlD
Telmisartan—ABCB1—prostate gland—prostate cancer	0.000375	0.0191	CbGeAlD
Telmisartan—ABCG2—testis—prostate cancer	0.000335	0.0171	CbGeAlD
Telmisartan—ABCC2—lymph node—prostate cancer	0.000333	0.017	CbGeAlD
Telmisartan—ABCB1—seminal vesicle—prostate cancer	0.000317	0.0162	CbGeAlD
Telmisartan—ABCB1—epithelium—prostate cancer	0.000275	0.014	CbGeAlD
Telmisartan—ABCB1—renal system—prostate cancer	0.000256	0.013	CbGeAlD
Telmisartan—ABCB1—urethra—prostate cancer	0.000251	0.0128	CbGeAlD
Telmisartan—ABCG2—lymph node—prostate cancer	0.000243	0.0124	CbGeAlD
Telmisartan—Losartan—CYP3A5—prostate cancer	0.000226	0.0672	CrCbGaD
Telmisartan—Losartan—ACE—prostate cancer	0.000208	0.062	CrCbGaD
Telmisartan—ABCB1—bone marrow—prostate cancer	0.000193	0.00984	CbGeAlD
Telmisartan—ABCB1—testis—prostate cancer	0.000165	0.00842	CbGeAlD
Telmisartan—Losartan—CYP2C19—prostate cancer	0.000154	0.0458	CrCbGaD
Telmisartan—ABCB1—lymph node—prostate cancer	0.00012	0.0061	CbGeAlD
Telmisartan—Losartan—CYP3A4—prostate cancer	9.78e-05	0.0291	CrCbGaD
Telmisartan—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.32e-05	0.000189	CcSEcCtD
Telmisartan—Headache—Mitoxantrone—prostate cancer	3.3e-05	0.000188	CcSEcCtD
Telmisartan—Hypotension—Capecitabine—prostate cancer	3.29e-05	0.000187	CcSEcCtD
Telmisartan—Insomnia—Docetaxel—prostate cancer	3.29e-05	0.000187	CcSEcCtD
Telmisartan—Arthralgia—Prednisone—prostate cancer	3.28e-05	0.000186	CcSEcCtD
Telmisartan—Myalgia—Prednisone—prostate cancer	3.28e-05	0.000186	CcSEcCtD
Telmisartan—Paraesthesia—Docetaxel—prostate cancer	3.27e-05	0.000186	CcSEcCtD
Telmisartan—Anxiety—Prednisone—prostate cancer	3.26e-05	0.000185	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—prostate cancer	3.26e-05	0.000185	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.25e-05	0.000185	CcSEcCtD
Telmisartan—Dyspnoea—Docetaxel—prostate cancer	3.25e-05	0.000184	CcSEcCtD
Telmisartan—Somnolence—Docetaxel—prostate cancer	3.24e-05	0.000184	CcSEcCtD
Telmisartan—Discomfort—Prednisone—prostate cancer	3.24e-05	0.000184	CcSEcCtD
Telmisartan—Eye disorder—Epirubicin—prostate cancer	3.23e-05	0.000184	CcSEcCtD
Telmisartan—Hypersensitivity—Etoposide—prostate cancer	3.23e-05	0.000183	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—prostate cancer	3.22e-05	0.000183	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.21e-05	0.000183	CcSEcCtD
Telmisartan—Flushing—Epirubicin—prostate cancer	3.21e-05	0.000182	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—prostate cancer	3.21e-05	0.000182	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—prostate cancer	3.21e-05	0.000182	CcSEcCtD
Telmisartan—Dyspepsia—Docetaxel—prostate cancer	3.21e-05	0.000182	CcSEcCtD
Telmisartan—Insomnia—Capecitabine—prostate cancer	3.19e-05	0.000181	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—prostate cancer	3.18e-05	0.000181	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—prostate cancer	3.17e-05	0.00018	CcSEcCtD
Telmisartan—Paraesthesia—Capecitabine—prostate cancer	3.17e-05	0.00018	CcSEcCtD
Telmisartan—Decreased appetite—Docetaxel—prostate cancer	3.17e-05	0.00018	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—prostate cancer	3.16e-05	0.000179	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—prostate cancer	3.15e-05	0.000179	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Docetaxel—prostate cancer	3.14e-05	0.000179	CcSEcCtD
Telmisartan—Asthenia—Etoposide—prostate cancer	3.14e-05	0.000179	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—prostate cancer	3.14e-05	0.000179	CcSEcCtD
Telmisartan—Dyspnoea—Capecitabine—prostate cancer	3.14e-05	0.000179	CcSEcCtD
Telmisartan—Oedema—Prednisone—prostate cancer	3.14e-05	0.000178	CcSEcCtD
Telmisartan—Anaphylactic shock—Prednisone—prostate cancer	3.14e-05	0.000178	CcSEcCtD
Telmisartan—Fatigue—Docetaxel—prostate cancer	3.14e-05	0.000178	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—prostate cancer	3.14e-05	0.000178	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—prostate cancer	3.14e-05	0.000178	CcSEcCtD
Telmisartan—Nausea—Mitoxantrone—prostate cancer	3.13e-05	0.000178	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—prostate cancer	3.12e-05	0.000177	CcSEcCtD
Telmisartan—Infection—Prednisone—prostate cancer	3.12e-05	0.000177	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—prostate cancer	3.12e-05	0.000177	CcSEcCtD
Telmisartan—Constipation—Docetaxel—prostate cancer	3.11e-05	0.000177	CcSEcCtD
Telmisartan—Pain—Docetaxel—prostate cancer	3.11e-05	0.000177	CcSEcCtD
Telmisartan—Dyspepsia—Capecitabine—prostate cancer	3.1e-05	0.000176	CcSEcCtD
Telmisartan—Chills—Epirubicin—prostate cancer	3.1e-05	0.000176	CcSEcCtD
Telmisartan—Pruritus—Etoposide—prostate cancer	3.1e-05	0.000176	CcSEcCtD
Telmisartan—Shock—Prednisone—prostate cancer	3.09e-05	0.000176	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—prostate cancer	3.09e-05	0.000175	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—prostate cancer	3.08e-05	0.000175	CcSEcCtD
Telmisartan—Nervous system disorder—Prednisone—prostate cancer	3.08e-05	0.000175	CcSEcCtD
Telmisartan—Tachycardia—Prednisone—prostate cancer	3.07e-05	0.000174	CcSEcCtD
Telmisartan—Decreased appetite—Capecitabine—prostate cancer	3.06e-05	0.000174	CcSEcCtD
Telmisartan—Skin disorder—Prednisone—prostate cancer	3.05e-05	0.000173	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Capecitabine—prostate cancer	3.04e-05	0.000173	CcSEcCtD
Telmisartan—Fatigue—Capecitabine—prostate cancer	3.04e-05	0.000173	CcSEcCtD
Telmisartan—Hyperhidrosis—Prednisone—prostate cancer	3.04e-05	0.000172	CcSEcCtD
Telmisartan—Mental disorder—Epirubicin—prostate cancer	3.03e-05	0.000172	CcSEcCtD
Telmisartan—Constipation—Capecitabine—prostate cancer	3.01e-05	0.000171	CcSEcCtD
Telmisartan—Pain—Capecitabine—prostate cancer	3.01e-05	0.000171	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—prostate cancer	3.01e-05	0.000171	CcSEcCtD
Telmisartan—Erythema—Epirubicin—prostate cancer	3.01e-05	0.000171	CcSEcCtD
Telmisartan—Feeling abnormal—Docetaxel—prostate cancer	3e-05	0.000171	CcSEcCtD
Telmisartan—Diarrhoea—Etoposide—prostate cancer	3e-05	0.00017	CcSEcCtD
Telmisartan—Anorexia—Prednisone—prostate cancer	2.99e-05	0.00017	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—prostate cancer	2.99e-05	0.00017	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—prostate cancer	2.98e-05	0.000169	CcSEcCtD
Telmisartan—Gastrointestinal pain—Docetaxel—prostate cancer	2.98e-05	0.000169	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—prostate cancer	2.97e-05	0.000169	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—prostate cancer	2.97e-05	0.000169	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—prostate cancer	2.97e-05	0.000168	CcSEcCtD
Telmisartan—Tension—Epirubicin—prostate cancer	2.95e-05	0.000168	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—prostate cancer	2.95e-05	0.000167	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—prostate cancer	2.92e-05	0.000166	CcSEcCtD
Telmisartan—Back pain—Epirubicin—prostate cancer	2.91e-05	0.000165	CcSEcCtD
Telmisartan—Feeling abnormal—Capecitabine—prostate cancer	2.91e-05	0.000165	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—prostate cancer	2.9e-05	0.000165	CcSEcCtD
Telmisartan—Dizziness—Etoposide—prostate cancer	2.9e-05	0.000165	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—prostate cancer	2.89e-05	0.000164	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—prostate cancer	2.89e-05	0.000164	CcSEcCtD
Telmisartan—Gastrointestinal pain—Capecitabine—prostate cancer	2.88e-05	0.000164	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—prostate cancer	2.88e-05	0.000164	CcSEcCtD
Telmisartan—Abdominal pain—Docetaxel—prostate cancer	2.88e-05	0.000164	CcSEcCtD
Telmisartan—Body temperature increased—Docetaxel—prostate cancer	2.88e-05	0.000164	CcSEcCtD
Telmisartan—Chills—Doxorubicin—prostate cancer	2.87e-05	0.000163	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Prednisone—prostate cancer	2.86e-05	0.000163	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—prostate cancer	2.86e-05	0.000162	CcSEcCtD
Telmisartan—Insomnia—Prednisone—prostate cancer	2.84e-05	0.000161	CcSEcCtD
Telmisartan—Paraesthesia—Prednisone—prostate cancer	2.82e-05	0.00016	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—prostate cancer	2.8e-05	0.000159	CcSEcCtD
Telmisartan—Urticaria—Capecitabine—prostate cancer	2.8e-05	0.000159	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—prostate cancer	2.79e-05	0.000159	CcSEcCtD
Telmisartan—Abdominal pain—Capecitabine—prostate cancer	2.79e-05	0.000158	CcSEcCtD
Telmisartan—Body temperature increased—Capecitabine—prostate cancer	2.79e-05	0.000158	CcSEcCtD
Telmisartan—Vomiting—Etoposide—prostate cancer	2.79e-05	0.000158	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—prostate cancer	2.78e-05	0.000158	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—prostate cancer	2.78e-05	0.000158	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—prostate cancer	2.78e-05	0.000158	CcSEcCtD
Telmisartan—Dyspepsia—Prednisone—prostate cancer	2.76e-05	0.000157	CcSEcCtD
Telmisartan—Rash—Etoposide—prostate cancer	2.76e-05	0.000157	CcSEcCtD
Telmisartan—Dermatitis—Etoposide—prostate cancer	2.76e-05	0.000157	CcSEcCtD
Telmisartan—Headache—Etoposide—prostate cancer	2.74e-05	0.000156	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—prostate cancer	2.74e-05	0.000156	CcSEcCtD
Telmisartan—Tension—Doxorubicin—prostate cancer	2.73e-05	0.000155	CcSEcCtD
Telmisartan—Decreased appetite—Prednisone—prostate cancer	2.73e-05	0.000155	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—prostate cancer	2.73e-05	0.000155	CcSEcCtD
Telmisartan—Malaise—Epirubicin—prostate cancer	2.71e-05	0.000154	CcSEcCtD
Telmisartan—Fatigue—Prednisone—prostate cancer	2.71e-05	0.000154	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—prostate cancer	2.7e-05	0.000154	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—prostate cancer	2.7e-05	0.000154	CcSEcCtD
Telmisartan—Syncope—Epirubicin—prostate cancer	2.7e-05	0.000153	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—prostate cancer	2.69e-05	0.000153	CcSEcCtD
Telmisartan—Constipation—Prednisone—prostate cancer	2.69e-05	0.000153	CcSEcCtD
Telmisartan—Hypersensitivity—Docetaxel—prostate cancer	2.68e-05	0.000152	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—prostate cancer	2.68e-05	0.000152	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—prostate cancer	2.66e-05	0.000151	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—prostate cancer	2.65e-05	0.00015	CcSEcCtD
Telmisartan—Cough—Epirubicin—prostate cancer	2.63e-05	0.000149	CcSEcCtD
Telmisartan—Asthenia—Docetaxel—prostate cancer	2.61e-05	0.000148	CcSEcCtD
Telmisartan—Nausea—Etoposide—prostate cancer	2.6e-05	0.000148	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—prostate cancer	2.6e-05	0.000148	CcSEcCtD
Telmisartan—Hypersensitivity—Capecitabine—prostate cancer	2.6e-05	0.000148	CcSEcCtD
Telmisartan—Feeling abnormal—Prednisone—prostate cancer	2.59e-05	0.000147	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—prostate cancer	2.58e-05	0.000147	CcSEcCtD
Telmisartan—Pruritus—Docetaxel—prostate cancer	2.58e-05	0.000146	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—prostate cancer	2.57e-05	0.000146	CcSEcCtD
Telmisartan—Gastrointestinal pain—Prednisone—prostate cancer	2.57e-05	0.000146	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—prostate cancer	2.56e-05	0.000146	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—prostate cancer	2.56e-05	0.000146	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—prostate cancer	2.56e-05	0.000146	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—prostate cancer	2.55e-05	0.000145	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.54e-05	0.000145	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—prostate cancer	2.53e-05	0.000144	CcSEcCtD
Telmisartan—Asthenia—Capecitabine—prostate cancer	2.53e-05	0.000144	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—prostate cancer	2.51e-05	0.000143	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—prostate cancer	2.51e-05	0.000142	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—prostate cancer	2.5e-05	0.000142	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—prostate cancer	2.5e-05	0.000142	CcSEcCtD
Telmisartan—Urticaria—Prednisone—prostate cancer	2.49e-05	0.000142	CcSEcCtD
Telmisartan—Pruritus—Capecitabine—prostate cancer	2.49e-05	0.000142	CcSEcCtD
Telmisartan—Diarrhoea—Docetaxel—prostate cancer	2.49e-05	0.000142	CcSEcCtD
Telmisartan—Abdominal pain—Prednisone—prostate cancer	2.48e-05	0.000141	CcSEcCtD
Telmisartan—Body temperature increased—Prednisone—prostate cancer	2.48e-05	0.000141	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—prostate cancer	2.46e-05	0.00014	CcSEcCtD
Telmisartan—Oedema—Epirubicin—prostate cancer	2.46e-05	0.00014	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—prostate cancer	2.46e-05	0.00014	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—prostate cancer	2.45e-05	0.000139	CcSEcCtD
Telmisartan—Infection—Epirubicin—prostate cancer	2.44e-05	0.000139	CcSEcCtD
Telmisartan—Cough—Doxorubicin—prostate cancer	2.43e-05	0.000138	CcSEcCtD
Telmisartan—Shock—Epirubicin—prostate cancer	2.42e-05	0.000137	CcSEcCtD
Telmisartan—Diarrhoea—Capecitabine—prostate cancer	2.41e-05	0.000137	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—prostate cancer	2.41e-05	0.000137	CcSEcCtD
Telmisartan—Dizziness—Docetaxel—prostate cancer	2.41e-05	0.000137	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—prostate cancer	2.4e-05	0.000137	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—prostate cancer	2.4e-05	0.000137	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—prostate cancer	2.4e-05	0.000136	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—prostate cancer	2.39e-05	0.000136	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—prostate cancer	2.37e-05	0.000135	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—prostate cancer	2.37e-05	0.000135	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—prostate cancer	2.37e-05	0.000135	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—prostate cancer	2.37e-05	0.000135	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—prostate cancer	2.36e-05	0.000134	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.35e-05	0.000134	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—prostate cancer	2.34e-05	0.000133	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—prostate cancer	2.34e-05	0.000133	CcSEcCtD
Telmisartan—Dizziness—Capecitabine—prostate cancer	2.33e-05	0.000132	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—prostate cancer	2.32e-05	0.000132	CcSEcCtD
Telmisartan—Vomiting—Docetaxel—prostate cancer	2.32e-05	0.000132	CcSEcCtD
Telmisartan—Hypersensitivity—Prednisone—prostate cancer	2.31e-05	0.000131	CcSEcCtD
Telmisartan—Rash—Docetaxel—prostate cancer	2.3e-05	0.00013	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—prostate cancer	2.3e-05	0.00013	CcSEcCtD
Telmisartan—Dermatitis—Docetaxel—prostate cancer	2.29e-05	0.00013	CcSEcCtD
Telmisartan—Headache—Docetaxel—prostate cancer	2.28e-05	0.00013	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—prostate cancer	2.27e-05	0.000129	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—prostate cancer	2.27e-05	0.000129	CcSEcCtD
Telmisartan—Infection—Doxorubicin—prostate cancer	2.26e-05	0.000128	CcSEcCtD
Telmisartan—Asthenia—Prednisone—prostate cancer	2.25e-05	0.000128	CcSEcCtD
Telmisartan—Vomiting—Capecitabine—prostate cancer	2.24e-05	0.000127	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.24e-05	0.000127	CcSEcCtD
Telmisartan—Shock—Doxorubicin—prostate cancer	2.24e-05	0.000127	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—prostate cancer	2.23e-05	0.000127	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—prostate cancer	2.23e-05	0.000126	CcSEcCtD
Telmisartan—Rash—Capecitabine—prostate cancer	2.22e-05	0.000126	CcSEcCtD
Telmisartan—Pruritus—Prednisone—prostate cancer	2.22e-05	0.000126	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—prostate cancer	2.22e-05	0.000126	CcSEcCtD
Telmisartan—Dermatitis—Capecitabine—prostate cancer	2.22e-05	0.000126	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—prostate cancer	2.22e-05	0.000126	CcSEcCtD
Telmisartan—Headache—Capecitabine—prostate cancer	2.21e-05	0.000125	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—prostate cancer	2.21e-05	0.000125	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—prostate cancer	2.21e-05	0.000125	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—prostate cancer	2.2e-05	0.000125	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—prostate cancer	2.19e-05	0.000124	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—prostate cancer	2.18e-05	0.000124	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—prostate cancer	2.17e-05	0.000123	CcSEcCtD
Telmisartan—Nausea—Docetaxel—prostate cancer	2.16e-05	0.000123	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—prostate cancer	2.16e-05	0.000123	CcSEcCtD
Telmisartan—Diarrhoea—Prednisone—prostate cancer	2.15e-05	0.000122	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—prostate cancer	2.14e-05	0.000121	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—prostate cancer	2.12e-05	0.000121	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—prostate cancer	2.12e-05	0.00012	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—prostate cancer	2.12e-05	0.00012	CcSEcCtD
Telmisartan—Pain—Epirubicin—prostate cancer	2.1e-05	0.000119	CcSEcCtD
Telmisartan—Constipation—Epirubicin—prostate cancer	2.1e-05	0.000119	CcSEcCtD
Telmisartan—Nausea—Capecitabine—prostate cancer	2.09e-05	0.000119	CcSEcCtD
Telmisartan—Dizziness—Prednisone—prostate cancer	2.08e-05	0.000118	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.07e-05	0.000118	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—prostate cancer	2.06e-05	0.000117	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—prostate cancer	2.04e-05	0.000116	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—prostate cancer	2.03e-05	0.000115	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—prostate cancer	2.02e-05	0.000115	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—prostate cancer	2.02e-05	0.000115	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—prostate cancer	2.01e-05	0.000114	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—prostate cancer	2e-05	0.000114	CcSEcCtD
Telmisartan—Vomiting—Prednisone—prostate cancer	2e-05	0.000113	CcSEcCtD
Telmisartan—Rash—Prednisone—prostate cancer	1.98e-05	0.000113	CcSEcCtD
Telmisartan—Dermatitis—Prednisone—prostate cancer	1.98e-05	0.000112	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—prostate cancer	1.98e-05	0.000112	CcSEcCtD
Telmisartan—Headache—Prednisone—prostate cancer	1.97e-05	0.000112	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.96e-05	0.000111	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—prostate cancer	1.96e-05	0.000111	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—prostate cancer	1.95e-05	0.000111	CcSEcCtD
Telmisartan—Pain—Doxorubicin—prostate cancer	1.94e-05	0.00011	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—prostate cancer	1.94e-05	0.00011	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—prostate cancer	1.94e-05	0.00011	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—prostate cancer	1.94e-05	0.00011	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—prostate cancer	1.87e-05	0.000106	CcSEcCtD
Telmisartan—Nausea—Prednisone—prostate cancer	1.87e-05	0.000106	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—prostate cancer	1.86e-05	0.000106	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—prostate cancer	1.81e-05	0.000103	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—prostate cancer	1.81e-05	0.000103	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—prostate cancer	1.8e-05	0.000102	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—prostate cancer	1.8e-05	0.000102	CcSEcCtD
Telmisartan—Asthenia—Epirubicin—prostate cancer	1.76e-05	0.0001	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—prostate cancer	1.74e-05	9.87e-05	CcSEcCtD
Telmisartan—Diarrhoea—Epirubicin—prostate cancer	1.68e-05	9.55e-05	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—prostate cancer	1.67e-05	9.51e-05	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—prostate cancer	1.63e-05	9.26e-05	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—prostate cancer	1.62e-05	9.23e-05	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—prostate cancer	1.61e-05	9.14e-05	CcSEcCtD
Telmisartan—Vomiting—Epirubicin—prostate cancer	1.56e-05	8.87e-05	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—prostate cancer	1.55e-05	8.84e-05	CcSEcCtD
Telmisartan—Rash—Epirubicin—prostate cancer	1.55e-05	8.8e-05	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—prostate cancer	1.55e-05	8.79e-05	CcSEcCtD
Telmisartan—Headache—Epirubicin—prostate cancer	1.54e-05	8.74e-05	CcSEcCtD
Telmisartan—Dizziness—Doxorubicin—prostate cancer	1.5e-05	8.54e-05	CcSEcCtD
Telmisartan—Nausea—Epirubicin—prostate cancer	1.46e-05	8.29e-05	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—prostate cancer	1.44e-05	8.21e-05	CcSEcCtD
Telmisartan—Rash—Doxorubicin—prostate cancer	1.43e-05	8.14e-05	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—prostate cancer	1.43e-05	8.13e-05	CcSEcCtD
Telmisartan—Headache—Doxorubicin—prostate cancer	1.42e-05	8.09e-05	CcSEcCtD
Telmisartan—Nausea—Doxorubicin—prostate cancer	1.35e-05	7.67e-05	CcSEcCtD
Telmisartan—CYP2C19—Metabolism—HSD3B1—prostate cancer	6.92e-06	8.21e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CAV1—prostate cancer	6.91e-06	8.19e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.89e-06	8.17e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1B1—prostate cancer	6.88e-06	8.16e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—prostate cancer	6.83e-06	8.1e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSD3B1—prostate cancer	6.76e-06	8.01e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC22A3—prostate cancer	6.76e-06	8.01e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	6.72e-06	7.96e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CREBBP—prostate cancer	6.68e-06	7.92e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTHFR—prostate cancer	6.67e-06	7.91e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GGT1—prostate cancer	6.67e-06	7.9e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ESR1—prostate cancer	6.66e-06	7.89e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA4—prostate cancer	6.64e-06	7.87e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TBXAS1—prostate cancer	6.64e-06	7.87e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CG—prostate cancer	6.57e-06	7.79e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NCOA1—prostate cancer	6.57e-06	7.78e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PPARA—prostate cancer	6.54e-06	7.76e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	6.54e-06	7.75e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	6.52e-06	7.73e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BAD—prostate cancer	6.5e-06	7.7e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	6.49e-06	7.69e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TBXAS1—prostate cancer	6.48e-06	7.68e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA4—prostate cancer	6.48e-06	7.68e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP19A1—prostate cancer	6.47e-06	7.67e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA2—prostate cancer	6.47e-06	7.67e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	6.39e-06	7.58e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SULT1A1—prostate cancer	6.39e-06	7.57e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCG5—prostate cancer	6.39e-06	7.57e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA2—prostate cancer	6.31e-06	7.48e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APC—prostate cancer	6.29e-06	7.46e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CG—prostate cancer	6.29e-06	7.46e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SERPINE1—prostate cancer	6.27e-06	7.43e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—RXRA—prostate cancer	6.25e-06	7.4e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTA1—prostate cancer	6.24e-06	7.4e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SULT1A1—prostate cancer	6.24e-06	7.39e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ABCG5—prostate cancer	6.24e-06	7.39e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGF—prostate cancer	6.22e-06	7.37e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IRS1—prostate cancer	6.22e-06	7.37e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—INS—prostate cancer	6.22e-06	7.37e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HSD3B2—prostate cancer	6.17e-06	7.32e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTO1—prostate cancer	6.17e-06	7.32e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NAT2—prostate cancer	6.17e-06	7.32e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CAV1—prostate cancer	6.15e-06	7.29e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTA1—prostate cancer	6.09e-06	7.22e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CREBBP—prostate cancer	6.09e-06	7.22e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GSK3B—prostate cancer	6.04e-06	7.16e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	6.04e-06	7.16e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTO1—prostate cancer	6.02e-06	7.14e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSD3B2—prostate cancer	6.02e-06	7.14e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NAT2—prostate cancer	6.02e-06	7.14e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—COMT—prostate cancer	6.02e-06	7.13e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—prostate cancer	5.99e-06	7.1e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—INS—prostate cancer	5.96e-06	7.06e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.93e-06	7.03e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLCB2—prostate cancer	5.92e-06	7.01e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LRP2—prostate cancer	5.92e-06	7.01e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2C18—prostate cancer	5.92e-06	7.01e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ITPR1—prostate cancer	5.89e-06	6.98e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.88e-06	6.97e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CREBBP—prostate cancer	5.84e-06	6.92e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—prostate cancer	5.83e-06	6.91e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—P4HB—prostate cancer	5.8e-06	6.88e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2C18—prostate cancer	5.78e-06	6.85e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLCB2—prostate cancer	5.78e-06	6.85e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LRP2—prostate cancer	5.78e-06	6.85e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CD—prostate cancer	5.77e-06	6.84e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1—prostate cancer	5.76e-06	6.83e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—prostate cancer	5.73e-06	6.8e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—P4HB—prostate cancer	5.66e-06	6.71e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC22A1—prostate cancer	5.64e-06	6.69e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CG—prostate cancer	5.6e-06	6.64e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.58e-06	6.61e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAP2K1—prostate cancer	5.57e-06	6.6e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TYMS—prostate cancer	5.57e-06	6.6e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	5.55e-06	6.58e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CD—prostate cancer	5.53e-06	6.56e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC22A1—prostate cancer	5.51e-06	6.53e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	5.51e-06	6.53e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—prostate cancer	5.5e-06	6.52e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SULT2A1—prostate cancer	5.5e-06	6.52e-05	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—prostate cancer	5.48e-06	6.5e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SERPINE1—prostate cancer	5.47e-06	6.49e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NOS3—prostate cancer	5.45e-06	6.46e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—prostate cancer	5.42e-06	6.42e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MED12—prostate cancer	5.41e-06	6.41e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—LPL—prostate cancer	5.4e-06	6.4e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—prostate cancer	5.38e-06	6.37e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SULT2A1—prostate cancer	5.37e-06	6.36e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNG5—prostate cancer	5.37e-06	6.36e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	5.37e-06	6.36e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—INS—prostate cancer	5.3e-06	6.29e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGF2—prostate cancer	5.3e-06	6.28e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MED12—prostate cancer	5.28e-06	6.26e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNG5—prostate cancer	5.24e-06	6.21e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOS3—prostate cancer	5.22e-06	6.19e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A1—prostate cancer	5.22e-06	6.18e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CREBBP—prostate cancer	5.2e-06	6.16e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ERCC2—prostate cancer	5.17e-06	6.13e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOA3—prostate cancer	5.17e-06	6.13e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.08e-06	6.02e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JAK2—prostate cancer	5.08e-06	6.02e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOA3—prostate cancer	5.05e-06	5.98e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CB—prostate cancer	5.03e-06	5.97e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—prostate cancer	4.99e-06	5.91e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—prostate cancer	4.98e-06	5.9e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MDM2—prostate cancer	4.96e-06	5.88e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HPGDS—prostate cancer	4.93e-06	5.85e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CD—prostate cancer	4.93e-06	5.84e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—prostate cancer	4.89e-06	5.79e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTHFR—prostate cancer	4.86e-06	5.76e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CB—prostate cancer	4.82e-06	5.72e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HPGDS—prostate cancer	4.82e-06	5.71e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2C19—prostate cancer	4.79e-06	5.67e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ACHE—prostate cancer	4.79e-06	5.67e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTT1—prostate cancer	4.79e-06	5.67e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARA—prostate cancer	4.77e-06	5.66e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2A6—prostate cancer	4.73e-06	5.61e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.71e-06	5.59e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTT1—prostate cancer	4.67e-06	5.54e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ACHE—prostate cancer	4.67e-06	5.54e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NOS3—prostate cancer	4.65e-06	5.51e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—prostate cancer	4.63e-06	5.49e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2A6—prostate cancer	4.62e-06	5.47e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKR1C3—prostate cancer	4.6e-06	5.45e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PRKACB—prostate cancer	4.58e-06	5.43e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	4.53e-06	5.37e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP17A1—prostate cancer	4.53e-06	5.37e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—prostate cancer	4.53e-06	5.36e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKR1C3—prostate cancer	4.49e-06	5.32e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAV1—prostate cancer	4.49e-06	5.32e-05	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—prostate cancer	4.48e-06	5.31e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.47e-06	5.3e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PRKACB—prostate cancer	4.47e-06	5.3e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—prostate cancer	4.44e-06	5.26e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—prostate cancer	4.43e-06	5.25e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP17A1—prostate cancer	4.42e-06	5.24e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—prostate cancer	4.41e-06	5.22e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.37e-06	5.18e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—prostate cancer	4.35e-06	5.15e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—prostate cancer	4.32e-06	5.12e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOA2—prostate cancer	4.32e-06	5.12e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CB—prostate cancer	4.29e-06	5.09e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—prostate cancer	4.28e-06	5.07e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—prostate cancer	4.25e-06	5.04e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOA2—prostate cancer	4.21e-06	4.99e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—prostate cancer	4.19e-06	4.97e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—prostate cancer	4.18e-06	4.95e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—prostate cancer	4.17e-06	4.94e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—EP300—prostate cancer	4.15e-06	4.92e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC5A5—prostate cancer	4.12e-06	4.88e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CG—prostate cancer	4.09e-06	4.84e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—prostate cancer	4.07e-06	4.82e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2E1—prostate cancer	4.02e-06	4.77e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC5A5—prostate cancer	4.02e-06	4.76e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NQO1—prostate cancer	3.98e-06	4.71e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EP300—prostate cancer	3.97e-06	4.71e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—prostate cancer	3.97e-06	4.7e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2E1—prostate cancer	3.93e-06	4.65e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TH—prostate cancer	3.92e-06	4.65e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.89e-06	4.62e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NQO1—prostate cancer	3.88e-06	4.6e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.88e-06	4.6e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—INS—prostate cancer	3.87e-06	4.58e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SRC—prostate cancer	3.86e-06	4.58e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.86e-06	4.57e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TH—prostate cancer	3.83e-06	4.53e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.81e-06	4.52e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CREBBP—prostate cancer	3.79e-06	4.49e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP3A4—prostate cancer	3.79e-06	4.49e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—prostate cancer	3.76e-06	4.46e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—prostate cancer	3.73e-06	4.42e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1B1—prostate cancer	3.72e-06	4.41e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—prostate cancer	3.71e-06	4.4e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GGT1—prostate cancer	3.69e-06	4.38e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOA1—prostate cancer	3.64e-06	4.31e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GGT1—prostate cancer	3.6e-06	4.27e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CD—prostate cancer	3.59e-06	4.26e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP19A1—prostate cancer	3.58e-06	4.25e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOA1—prostate cancer	3.55e-06	4.21e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—EP300—prostate cancer	3.54e-06	4.19e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP19A1—prostate cancer	3.5e-06	4.15e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—prostate cancer	3.46e-06	4.11e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—RXRA—prostate cancer	3.46e-06	4.1e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—prostate cancer	3.45e-06	4.1e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NOS3—prostate cancer	3.39e-06	4.02e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—prostate cancer	3.39e-06	4.02e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—RXRA—prostate cancer	3.38e-06	4e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.36e-06	3.99e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—COMT—prostate cancer	3.33e-06	3.95e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—prostate cancer	3.32e-06	3.93e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ITPR1—prostate cancer	3.26e-06	3.87e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—COMT—prostate cancer	3.25e-06	3.86e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—prostate cancer	3.24e-06	3.84e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.21e-06	3.8e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—prostate cancer	3.2e-06	3.79e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ITPR1—prostate cancer	3.19e-06	3.78e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CB—prostate cancer	3.13e-06	3.71e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—prostate cancer	3.1e-06	3.68e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TYMS—prostate cancer	3.08e-06	3.66e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—prostate cancer	3.07e-06	3.64e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—prostate cancer	3.05e-06	3.61e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TYMS—prostate cancer	3.01e-06	3.57e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LPL—prostate cancer	2.99e-06	3.55e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—prostate cancer	2.98e-06	3.53e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—prostate cancer	2.94e-06	3.48e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LPL—prostate cancer	2.92e-06	3.46e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.89e-06	3.43e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ERCC2—prostate cancer	2.87e-06	3.4e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—prostate cancer	2.84e-06	3.37e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A1—prostate cancer	2.82e-06	3.34e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ERCC2—prostate cancer	2.8e-06	3.32e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—prostate cancer	2.75e-06	3.26e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—prostate cancer	2.71e-06	3.21e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTHFR—prostate cancer	2.69e-06	3.19e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARA—prostate cancer	2.64e-06	3.13e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTHFR—prostate cancer	2.63e-06	3.12e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—prostate cancer	2.62e-06	3.1e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—prostate cancer	2.6e-06	3.09e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—EP300—prostate cancer	2.58e-06	3.06e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARA—prostate cancer	2.58e-06	3.06e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—prostate cancer	2.51e-06	2.97e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAV1—prostate cancer	2.48e-06	2.95e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAV1—prostate cancer	2.43e-06	2.87e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—prostate cancer	2.4e-06	2.85e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.37e-06	2.81e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.26e-06	2.68e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CG—prostate cancer	2.21e-06	2.62e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—INS—prostate cancer	2.14e-06	2.54e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—prostate cancer	2.14e-06	2.53e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CREBBP—prostate cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—INS—prostate cancer	2.09e-06	2.48e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CREBBP—prostate cancer	2.05e-06	2.43e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.99e-06	2.36e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CD—prostate cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—prostate cancer	1.91e-06	2.26e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NOS3—prostate cancer	1.88e-06	2.23e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NOS3—prostate cancer	1.83e-06	2.17e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.73e-06	2.06e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—prostate cancer	1.72e-06	2.04e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CB—prostate cancer	1.69e-06	2.01e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—prostate cancer	1.68e-06	1.99e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—prostate cancer	1.56e-06	1.85e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—prostate cancer	1.5e-06	1.78e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—prostate cancer	1.46e-06	1.73e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—EP300—prostate cancer	1.43e-06	1.69e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—EP300—prostate cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.06e-06	1.25e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—prostate cancer	1.03e-06	1.22e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—prostate cancer	8.64e-07	1.02e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—prostate cancer	8.43e-07	9.99e-06	CbGpPWpGaD
